Inaki Perez
Barcelona, CT, Spain
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 21 publications
MicroRNA Profile in CD8+ T-Lymphocytes from HIV-Infected Individuals: Relationship with Antiviral Immune Response and Disease Progression.
Journal: PloS one
Published: February 03, 2016
Safe Reduction in CD4 Cell Count Monitoring in Stable, Virally Suppressed Patients With HIV Infection or HIV/Hepatitis C Virus Coinfection.
Journal: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America
Published: November 13, 2015
Improvement of lipoatrophy by switching from efavirenz to lopinavir/ritonavir.
Journal: HIV medicine
Published: July 30, 2015
Prediction of higher cost of antiretroviral therapy (ART) according to clinical complexity. A validated clinical index.
Journal: Enfermedades infecciosas y microbiologia clinica
Published: May 07, 2015
Immune Reconstitution in Severely Immunosuppressed Antiretroviral-Naive HIV-1-Infected Patients Starting Efavirenz, Lopinavir-Ritonavir, or Atazanavir-Ritonavir Plus Tenofovir/Emtricitabine: Final 48-Week Results (The Advanz-3 Trial).
Journal: Journal of acquired immune deficiency syndromes (1999)
Published: April 02, 2015
Contribution of genetic background and antiretroviral therapy to body fat changes in antiretroviral-naive HIV-infected adults.
Journal: The Journal of antimicrobial chemotherapy
Published: September 04, 2014
Pegylated interferon plus ribavirin in HIV-infected patients with recurrent hepatitis C after liver transplantation: a prospective cohort study.
Journal: Journal of hepatology
Published: June 10, 2014
Abacavir/lamivudine plus darunavir/ritonavir in routine clinical practice: a multicentre experience in antiretroviral therapy-naive and -experienced patients.
Journal: The Journal of antimicrobial chemotherapy
Published: May 17, 2014
Impact of prior virological failure and nucleos(t)ide genotypic resistance mutations on the efficacy of switching from ritonavir-boosted protease inhibitors to raltegravir.
Journal: Antiviral therapy
Published: May 06, 2014
Acute outbreak of hepatitis C in human immunodeficiency virus-infected patients
Journal: Enfermedades infecciosas y microbiologia clinica
Published: November 07, 2013
Early lipid changes with atazanavir/ritonavir or darunavir/ritonavir.
Journal: HIV medicine
Published: November 05, 2013
Dual therapy with etravirine plus raltegravir for virologically suppressed HIV-infected patients: a pilot study.
Journal: The Journal of antimicrobial chemotherapy
Published: October 17, 2013
Last Updated: 09/26/2026